Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study

Ambica Parmar, MD, Heather A Leitch, MD PhD, Richard A. Wells, MD DPhil, Thomas J. Nevill, MD FRCPC, Nancy Y Zhu, MDFRCPC, Karen W.L. Yee, MD, Brian Leber, MD, Mitchell Sabloff, MDM, Eve St-Hilaire, MD, Rajat Kumar, MD, Michelle Geddes, MD FRCPC, John Storring, MD, Andrea Kew, MD, April Shamy, MDM, Mohamed Elemary, MD MSc,PhD, Martha Lenis, Alex Mamedov, Rena Buckstein, MD FRCPC

Blood (2015) 126 (23): 1701.

https://doi.org/10.1182/blood.V126.23.1701.1701

Published: 2015

Journal Articles

Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry

Rena Buckstein, MD, Richard A. Wells, MD DPhil, Nancy Zhu, MD, Thomas J. Nevill, MD, Heather A Leitch, MD PhD, Karen W.L. Yee, MD, Brian Leber, MD, Mitchell Sabloff, MDM, Rajat Kumar, MD, Michelle Geddes, MD, April Shamy, MDM, Max Levitt, Martha Lenis, Alex Mamedov, Liying Zhang, PhD, Shabbir MH Alibhai, MD

Blood (2014) 124 (21): 165.

https://doi.org/10.1182/blood.V124.21.165.165

Published: 2014

Journal Articles

Autoimmune Cytopenia in Chronic Lymphocytic Leukemia: Effect on Outcome and Survival, a Population Based Analysis in British Columbia, Canada

Alaa A Alzaki, MBBS, Alina S Gerrie, MD, Tanya L. Gillan, PhD FCCMG, Steven Huang, Miriam Ahmed, Cynthia L. Toze, MD FRCPC, Heather A Leitch, MD PhD, Khaled M Ramadan, MB

Blood (2014) 124 (21): 1945.

https://doi.org/10.1182/blood.V124.21.1945.1945

Published: 2014

Journal Articles

Association Between Increased Liver Iron Concentration and Vitamin D Deficiency in Patients with Transfusion Dependent Hemoglobinopathies in British Columbia

Hatoon Ezzat, MBBS, FRCP, ABIM, John K. Wu, MBBS, FRCPC, Heather McCartney, Heather A Leitch, MD, PhD

Blood (2012) 120 (21): 3203.

https://doi.org/10.1182/blood.V120.21.3203.3203

Published: 2012

Journal Articles

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Heather A Leitch, MD, PhD, FRCPC, Christopher Chan, Chantal S Leger, MD, FRCP(C), Lynda M Foltz, MD, FRCP(C), Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Linda M Vickars, MD, FRCP(C)

Blood (2011) 118 (21): 1732.

https://doi.org/10.1182/blood.V118.21.1732.1732

Published: 2011

Journal Articles

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

Hatoon Ezzat, MBBS, FRCP, ABIM, R. Robert Schellenberg, Heather A Leitch, MD, PhD, FRCPC, Linda M Vickars, MD, FRCP(C)

Blood (2011) 118 (21): 5280.

https://doi.org/10.1182/blood.V118.21.5280.5280

Published: 2011

Journal Articles

A Canadian Expanded Access Trial of Oral Nilotinb in Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Robert Delage, MD, MSc, FRCP, A. Robert Turner, MD, FRCPC, Brian Leber, MD, Wanda S. Hasegawa, MD, Denis-Claude Roy, MD, Mary Lynn Savoie, MD, Heather A Leitch, MD, PhD, Isabelle Bence-Bruckler, MD, FRCPC, Donna L. Forrest, MD, Sindu Kanjeekal, MD, Sehdev Sandeep, MD, Pierre Laneuville, MD, Sarit Assouline, MD, Kuljit Grewal, MD, Michael J. Kovacs, MD, FRCPC, Wendy Lam, MD, Annie Woo, M.Sc., Pierre Beauparlant, Ph.D., Jeffrey H. Lipton, MD, PhD

Blood (2011) 118 (21): 4437.

https://doi.org/10.1182/blood.V118.21.4437.4437

Published: 2011

Journal Articles

HIV-Associated Thrombotic Thrombocytopenic Purpura

Jordana Boro, Katerina Pavenski, MD, FRCP, Kimberley L.S. Ambler, MD, FRCPC, Heather A Leitch, MD, PhD, Lisa K Hicks, MD, MSc, FRCPC

Blood (2011) 118 (21): 4677.

https://doi.org/10.1182/blood.V118.21.4677.4677

Published: 2011

Journal Articles

Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease

Musa Alzahrani, MD, Mark C Hull, MD, Christopher Sherlock, MD, Deborah Griswold, MD, Chantal S Leger, MD, Shannon Jackson, MD, Christopher P Venner, BSc, MD, Tyler W Smith, MD, Heather A Leitch, MD, PhD

Blood (2010) 116 (21): 3897.

https://doi.org/10.1182/blood.V116.21.3897.3897

Published: 2010

Journal Articles

Clinical Features, Treatment, and Outcome of Severe HIV-Associated Immune Thrombocytopenic Purpura In the HAART Era

Kimberley LS Ambler, MD, FRCP(C), Linda M Vickars, MD, FRCP(C), Chantal S Leger, MD, FRCP(C), Lynda M Foltz, MD, FRCP(C), Julio SG Montaner, MD, FRCPC, FCCP, Marianne Harris, MD, FRCPC, Heather A Leitch, MD, PhD, FRCP(C)

Blood (2010) 116 (21): 2522.

https://doi.org/10.1182/blood.V116.21.2522.2522

Published: 2010

Journal Articles

Incorporation of ANTI-HHV-8 Agents as Targeted Therapy for the Treatment of HIV-Associated Primary Effusion Lymphoma.

Laura M Kuyper, MD, Mark Hull, MD, Peter Phillips, MD, Julio SG Montaner, MD, Heather A Leitch, MD, PhD

Blood (2009) 114 (22): 4768.

https://doi.org/10.1182/blood.V114.22.4768.4768

Published: 2009

Journal Articles

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome.

Maha A Badawi, MD, Linda M Vickars, MD, Jocelyn M Chase, MD, Heather A Leitch, MD, PhD

Blood (2009) 114 (22): 4844.

https://doi.org/10.1182/blood.V114.22.4844.4844

Published: 2009

Journal Articles

Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma

Hatoon Ezzat, MD, Matthew C Cheung, MD, SM, Lisa K Hicks, MD, MSc, Kevin C Murphy, MD, Chantal S Leger, MD, Linda R Taggart, MD, Jordana Boro, Julio SG Montaner, MD, Marianne Harris, MD, Linda M Vickars, MD, Heather A Leitch, MD, PhD

Blood (2008) 112 (11): 2587.

https://doi.org/10.1182/blood.V112.11.2587.2587

Published: 2008

Journal Articles

Improved Leukemia-Free and Overall Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy: A Subgroup Analysis.

Heather A. Leitch, MD, PhD, Dominic H.C. Wong, Chantal S. Leger, MD, Khaled M. Ramadan, MD, Meaghan D. Rollins, BHK, Michael J. Barnett, MB, Trisha A. Goodman, BHK, Karen K. Wong, Paul F. Galbraith, MD, Linda M. Vickars, MD

Blood (2007) 110 (11): 1469.

https://doi.org/10.1182/blood.V110.11.1469.1469

Published: 2007

Journal Articles

Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.

Heather A. Leitch, MD, PhD, Hatoon Ezzat, MD, Meaghan D. Rollins, BHK, Dominic H.C. Wong, Chantal S. Leger, MD, Khaled M. Ramadan, MD, Michael J. Barnett, MB, Linda M. Vickars, MD

Blood (2007) 110 (11): 4653.

https://doi.org/10.1182/blood.V110.11.4653.4653

Published: 2007

Journal Articles

Improved Survival in Patients with Myelodysplastic Syndrome (MDS) Receiving Iron Chelation Therapy.

Heather A. Leitch, MD, PhD, Trisha A. Goodman, BHK, Karen K. Wong, Linda M. Vickars, MD, Paul F. Galbraith, MD, Chantal S. Leger, MD

Blood (2006) 108 (11): 249.

https://doi.org/10.1182/blood.V108.11.249.249

Published: 2006

Journal Articles

Physician Perceptions and Preferences in the Treatment of Acquired Immunodeficiency Syndrome (AIDS)-Related Lymphoma (ARL).

Matthew C. Cheung, MD, Mona R. Loutfy, MD, MPH, Heather A. Leitch, MD, PhD, Rena Buckstein, MD, Kevin R. Imrie

Blood (2006) 108 (11): 3331.

https://doi.org/10.1182/blood.V108.11.3331.3331

Published: 2006

Journal Articles

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Hatoon Ezzat, MD, Douglas Filipinko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4666.

https://doi.org/10.1182/blood.V108.11.4666.4666

Published: 2006

Journal Articles

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

Hatoon Ezzat, MD, Jonathan C. Wong, BHSc, Douglas Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4667.

https://doi.org/10.1182/blood.V108.11.4667.4667

Published: 2006

Journal Articles

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Hatoon Ezzat, MD, J. Doug Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio Montaner, MD, Marianne Harris, MD, Robert Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4674.

https://doi.org/10.1182/blood.V106.11.4674.4674

Published: 2005

NARROW

Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study

Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry

Autoimmune Cytopenia in Chronic Lymphocytic Leukemia: Effect on Outcome and Survival, a Population Based Analysis in British Columbia, Canada

Association Between Increased Liver Iron Concentration and Vitamin D Deficiency in Patients with Transfusion Dependent Hemoglobinopathies in British Columbia

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

A Canadian Expanded Access Trial of Oral Nilotinb in Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

HIV-Associated Thrombotic Thrombocytopenic Purpura

Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease

Clinical Features, Treatment, and Outcome of Severe HIV-Associated Immune Thrombocytopenic Purpura In the HAART Era

Incorporation of ANTI-HHV-8 Agents as Targeted Therapy for the Treatment of HIV-Associated Primary Effusion Lymphoma.

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome.

Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma

Improved Leukemia-Free and Overall Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy: A Subgroup Analysis.

Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.

Improved Survival in Patients with Myelodysplastic Syndrome (MDS) Receiving Iron Chelation Therapy.

Physician Perceptions and Preferences in the Treatment of Acquired Immunodeficiency Syndrome (AIDS)-Related Lymphoma (ARL).

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only